Barclays Maintains Overweight Rating for Baxter Intl: Here’s What You Need To Know
Barclays has decided to maintain its Overweight rating of Baxter Intl (NYSE:BAX) and raise its price target from…
Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit
Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, Therapies, Kidney Care, and Pharmaceuticals segments.
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell
• Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Don’t Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street’s Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Morgan Stanley Maintains Equal-Weight Rating for Baxter Intl: Here’s What You Need To Know
Morgan Stanley has decided to maintain its Equal-Weight rating of Baxter Intl (NYSE:BAX) and lower its price target…
Baxter Highlights New Data At Kidney Week Indicating Sharesource Is Associated With A 77% Lower Risk Of Home Dialysis Technique Failure
Additional key data presented at the congress indicates how HDx therapy enabled by Theranova dialyzer is helping advance "green" nephrologyIn total, Baxter supported 17 clinical presentations to advance scientific
Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.71 billion, which beat the consensus of $3.69 billion, up 3% Y/Y on a reported basis and
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell
• AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Earnings Outlook For Baxter Intl
Baxter Intl (NYSE:BAX) is set to give its latest quarterly earnings report on Thursday, 2023-11-02. Here’s what investors…
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in first-line hepatocellular carcinoma study.